6533b86dfe1ef96bd12ca836
RESEARCH PRODUCT
1122P Real-world analysis of dabrafenib plus trametinib in patients with BRAFV600-mutated melanoma brain metastases
Ralf GutzmerPeter MohrMichael WeichenthalThomas EigentlerD. DebusCarmen LoquaiFelix KieckerCarola BerkingU. Leiter-stöppkeK. SchoberDirk Schadendorfsubject
OncologyTrametinibmedicine.medical_specialtybusiness.industryMelanomaDabrafenibHematologymedicine.diseaseOncologyInternal medicinemedicineIn patientbusinessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2020-09-01 | Annals of Oncology |